Is there a role of magnetic resonance imaging in deciding to stop anti-tumor necrosis factor treatment in ileal Crohn's disease?

被引：5
作者：
Gallego, Jose C. [1 ]
Echarri, Ana [2 ]
机构：
[1] Complexo Hosp Univ Ferrol, Radiol Dept, Av Residencia S-N, Ferrol 15405, Spain
[2] Complexo Hosp Univ Ferrol, Gastroenterol Dept, Ferrol, Spain
来源：
CLINICAL IMAGING | 2017年 / 43卷
关键词：
Crohn's disease; Magnetic resonance imaging; Anti-tumor necrosis factor agents; INFLAMMATORY-BOWEL-DISEASE; INFLIXIMAB THERAPY; CLINICAL REMISSION; FOLLOW-UP; DISCONTINUATION; MAINTENANCE; RELAPSE;
D O I：
10.1016/j.clinimag.2017.03.010
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Purpose: This study was performed to assess the ability of magnetic resonance enterography to predict the evolution of patients in whom anti-tumor necrosis factor-alpha therapy was suspended. Methods: A prospective study of patients with ileal Crohn's disease was performed. Results: Twenty-nine patients were included. Patients who later relapsed showed higher magnetic resonance scores than those who did not relapse (4.2 vs. 2.5, respectively; p < 0.02). The area under the receiving-operating characteristics curve was 0.755 when discriminating patients who relapsed. Conclusions: Magnetic resonance enterography should be taken into account when deciding the withdrawal of anti-tumor necrosis factor-alpha in patients with Crohn's disease. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码：175 / 179
页数：5
相关论文
共 50 条
  • [31] Earlier Anti-Tumor Necrosis Factor Therapy of Crohn's Disease Correlates with Slower Progression of Bowel Damage
    Panchal, Hinaben
    Wagner, Mathilde
    Chatterji, Manjil
    Taouli, Bachir
    McBride, Russell
    Patterson, Jeromy R.
    Ungaro, Ryan
    Dubinsky, Marla
    Cho, Judy
    Sachar, David B.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (11) : 3274 - 3283
  • [32] Emergence of Crohn's Disease During Treatment with the Anti-Tumor Necrosis Factor Agent Etanercept for Ankylosing Spondylitis: Possible Mechanisms of Action
    Haraoui, Boulos
    Krelenbaum, Marilyn
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 39 (03) : 176 - 181
  • [33] The Role of Magnetic Resonance Imaging in Detecting Intestinal Fibrosis in Crohn's Disease
    Fiorino, Gionata
    Cesarini, Monica
    Malesci, Alberto
    Danese, Silvio
    Sorrentino, Dario
    CURRENT DRUG TARGETS, 2012, 13 (10) : 1273 - 1279
  • [34] Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
    Siegel, Corey A.
    Marden, Sadie M.
    Persing, Sarah M.
    Larson, Robin J.
    Sands, Bruce E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (08) : 874 - 881
  • [35] Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease
    Zaccagna, A
    Bertone, A
    Puiatti, P
    Picciotto, F
    Sprujevnik, T
    Santucci, R
    Rossini, FP
    EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (03) : 258 - 260
  • [36] Tumor necrosis factor-alpha in ileal mast cells in patients with Crohn's disease
    Lilja, I
    Gustafson-Svärd, C
    Franzén, L
    Sjödahl, R
    DIGESTION, 2000, 61 (01) : 68 - 76
  • [37] Advancing Magnetic Resonance Imaging in Crohn's Disease
    Fujii, Toshimitsu
    Naganuma, Makoto
    Kitazunne, Yoshio
    Saito, Elko
    Nagahori, Masakazu
    Ohtsuka, Kazuo
    Watanabe, Mamoru
    DIGESTION, 2014, 89 (01) : 24 - 30
  • [38] Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease
    Fernandes, Carlos
    Allocca, Mariangela
    Danese, Silvio
    Fiorino, Gionata
    IMMUNOTHERAPY, 2015, 7 (02) : 175 - 190
  • [39] The Effect of Anti-Tumor Necrosis Factor Alpha Agents on Postoperative Anastomotic Complications in Crohn's Disease: a Systematic Review
    El-Hussuna, Alaa
    Krag, Aleksander
    Olaison, Gunnar
    Bendtsen, Flemming
    Gluud, Lise L.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (12) : 1423 - 1433
  • [40] Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease
    Plevris, Nikolas
    Jenkinson, Philip W.
    Arnott, Ian D.
    Jones, Gareth R.
    Lees, Charlie W.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (01) : 32 - 37
12345